Labcorp’s Stock Price Target Raised on Strong Q1 (NYSE: LH)
Baird updated its price target on Laboratory Corporation of America Holdings, commonly known as Labcorp, to $267 from $253, while maintaining an Outperform rating on the shares. This adjustment reflects a positive stance by the firm following Labcorp’s Q1 results, suggesting an expectation of sustained growth and performance by the healthcare diagnostics company.
Labcorp’s stock, traded on the New York Stock Exchange under the ticker symbol LH, has experienced a notable increase in its trading price over the past 5 days, with a gain of 8.44%.
The positive outlook on Labcorp by Baird demonstrates a belief in the company’s substantial growth potential. A key factor behind such optimism is the company’s performance in the…
